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Abstract:  Chronic  pulmonary  aspergillosis
underlying pulmonary diseases described. Here we report the association of chronic pulmonary 
aspergillosis and long term marijuana smoking in 2 patients and review the literature related to 
invasive and allergic aspergillosis. 
Introduction: Marijuana is the most commonly used 
illicit  substance  in  the  UK  and  many  other  western 
countries, despite it being a class B drug. It is available 
legally  in  some localities,  including the  Netherlands. 
There is a well known link between marijuana use and 
schizophrenia. There is currently uncertainty about any 
causal  association  between  marijuana  use  and  lung 
cancer as the effects of concomitant tobacco smoking 
amongst  these  users  confound  analyses.  A  small 
number of cases of various forms of aspergillosis h
been  associated  with  marijuana  smoking,  but  the 
association appears to be uncommon.
1-9
We  present  2  cases  of  chronic  pulmonary 
aspergillosis  (CPA)  associated  with  extensive 
medicinal  use  of  marijuana,  and  summarise  the 
literature  linking  all  forms  of  aspergillosis  and 
marijuana use. 
Case reports 
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Chronic  pulmonary  aspergillosis is  a  progressive  debilitating  disease  with  multiple 
underlying pulmonary diseases described. Here we report the association of chronic pulmonary 
aspergillosis and long term marijuana smoking in 2 patients and review the literature related to 
allergic aspergillosis. 
Marijuana is the most commonly used 
illicit  substance  in  the  UK  and  many  other  western 
countries, despite it being a class B drug. It is available 
legally  in  some localities,  including the  Netherlands. 
There is a well known link between marijuana use and 
chizophrenia. There is currently uncertainty about any 
causal  association  between  marijuana  use  and  lung 
cancer as the effects of concomitant tobacco smoking 
amongst  these  users  confound  analyses.  A  small 
number of cases of various forms of aspergillosis have 
been  associated  with  marijuana  smoking,  but  the 
9
We  present  2  cases  of  chronic  pulmonary 
aspergillosis  (CPA)  associated  with  extensive 
medicinal  use  of  marijuana,  and  summarise  the 
aspergillosis  and 
Patient 1: A Caucasian male presented at the age of 47 
with a right-sided pneumothorax (
with pulmonary bullae. He had a four year history of 
progressive  breathlessness.  His  tobacco  smok
history  was  approximately  39  pack*years,  but  his 
breathlessness worsened considerably once he started 
to  smoke  marijuana  (5  marijuana  cigarettes  (joints) 
daily)  medicinally  to  alleviate  rheumatoid  arthritis
associated  joint  pain.    On  presentation,  he  r
coughing  up  thick  sputum  and  experiencing  some 
unexpected  weight  loss.  His  medications  included  a 
5mg  daily  dose  of  prednisolone  and  1g  dose  of 
sulfasalazine twice a day. His family history included 
one  brother  who  had  TB  and  another  who  had  a 
pneumothorax.
His pneumothorax did not resolve despite drainage; 
thus he underwent a right bullectomy and pleurectomy. 
One  of  the  excised  bullae    (
pleural based   abscess   containing
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is  a  progressive  debilitating  disease  with  multiple 
underlying pulmonary diseases described. Here we report the association of chronic pulmonary 
aspergillosis and long term marijuana smoking in 2 patients and review the literature related to 
A Caucasian male presented at the age of 47 
sided pneumothorax (Figure 1), associated 
with pulmonary bullae. He had a four year history of 
progressive  breathlessness.  His  tobacco  smoking 
history  was  approximately  39  pack*years,  but  his 
breathlessness worsened considerably once he started 
to  smoke  marijuana  (5  marijuana  cigarettes  (joints) 
daily)  medicinally  to  alleviate  rheumatoid  arthritis-
associated  joint  pain.    On  presentation,  he  reported 
coughing  up  thick  sputum  and  experiencing  some 
unexpected  weight  loss.  His  medications  included  a 
5mg  daily  dose  of  prednisolone  and  1g  dose  of 
sulfasalazine twice a day. His family history included 
one  brother  who  had  TB  and  another  who  had  a 
His pneumothorax did not resolve despite drainage; 
thus he underwent a right bullectomy and pleurectomy. 
One  of  the  excised  bullae    (Figure  2)  contained  a 
containing an   aspergillomaMediterr J Hematol Infect Dis 2011, 3; Open Journal System
Figure 1. Patient 1. Bilateral apical bullae, more marked on the 
right; associated with a right pneumothorax.
Figure 2. Appearance of the resected lung showing remarkable loss 
of  normal  lung  architecture,  and  large  airspaces,  especially  in 
section B.
(Figure 3). His CRP at this time was 333mg/l. Post-
operatively his lung function failed to improve and a 
chest x-ray revealed that that his right lung remained 
abnormal, with cavitary changes. A CT scan showed 
severe  emphysema  with  many  large  lung  bullae 
especially   in   the left   apex   (Figure 4).   His   CRP 
Figure 3. Appearance of the fungal ball found at surgery.
normalised  and  his  alpha  1  antitrypsin  levels  were 
normal.
Pathological  evidence  of  an  aspergilloma with 
symptoms  of  weight  loss  and  raised  inflammatory 
markers is an indication for antifungal therapy. He was 
started on posaconazole 400mg bd and took it for 4 
months.  After treatment both his cough and sputum 
production  improved  and  his  Aspergillus  fumigatus
precipitin  serum  titre  was  1:4.  He  stopped  smoking 
marijuana. He was observed for recurrence of CPA for 
the  following 4  years  and there  was  no  evidence  of 
recurrence (Figure 5).
Patient  2: A  35  year-old  Caucasian  male  presented 
with shortness of breath secondary to a viral infection.
After  investigations  he  was  diagnosed  with
Figure 4. Patient 1 Postoperative CT thorax showing many large 
lung bullae in left apex with smaller bullae, and a bullectomy suture 
line in the right.  The aspergilloma and surrounding cavity that was 
found has been excised.Mediterr J Hematol Infect Dis 2011, 3; Open Journal System
Figure  5. Patient  1  Chest  radiograph  3  years  later,  showing
generalised  emphysema  but  no  recurrence  of  chronic  pulmonary
aspergillosis
emphysema.  He  had  been  born  with  a  Tetralogy  of 
Fallot congenital heart malformation and underwent a 
surgical  repair  at  the  age  of  10.  Post-operatively  he 
experienced  immense  pain  and  started  smoking 
cannabis, without tobacco, to reduce it.  He continued 
to grow his own marijuana and smoke several joints 
daily.
He  remained  apparently  well  until  admission  to 
Figure 6. Patient 2 Chest radiograph, showing extensive loss of 
lung architecture, 2 curvilinear opacities in the left base and the 
upper left mediastinum representing compressed lung from adjacent 
bullae formation. On the left side there is parenchymal shadowing 
and the impression of thin walled cavities just above the hilum.  
hospital  aged  43,  and  then  several  times  over  the 
following  two  years,  owing  to  type  II  respiratory
failure. Aged 44, he stopped smoking cannabis,ending 
34  years  of  smoking  around  20  joints  per  day. 
Despitestopping  smoking  cannabis  his  respiratory 
function  had  diminished  to  such  an  extent  that  his 
exercise tolerance was only 10 yards on the flat. As a 
result  he  was  started  on  long  term  oxygen  therapy, 
requiring  3L  continuously  to  maintain  an  oxygen 
saturation of 91%.
By  45  years  his  FEV1 was  only  11%  predicted  and
Figure 7. Patient 2 CT scan cuts of the thorax showing extensive 
bullae formation on the right, cavitation posteriorly on the left, with 
fungal  material  present  in  a  cavity  on  the  second  section,  and 
additional areas of cavitation in the right lower lobe, with slightly 
thicker walls and pleural involvement.Mediterr J Hematol Infect Dis 2011, 3; Open Journal System
his  FVC  was  22%  predicted.  A  CT  scan revealed  
“severe  pan-acinar  emphysema  involving  the  right 
upper  and middle  lobes; complex  cavitary  lesions in 
the left apex, one of which had the appearance of an 
aspergilloma”  (Figure  7).  Sputum  culture  revealed 
Aspergillus fumigatus. His Aspergillus precipitins titre 
was  1:8  and  his Aspergillus IgG  antibody  level 
(Immunocap, Phadia) was 126mg/L. His total IgE was 
180 and he had a positive Aspergillus RAST of 0.4, all 
consistent  with  chronic  pulmonary  aspergillosis.  His 
respiratory function deteriorated such that he required a 
lung  transplant;  however  the  discovery  of  an 
aspergilloma  was  seen  to  be  an  absolute 
contraindication  by  the  team  treating  him.  He  was 
started  on  voriconazole  200mg  bd  with  some 
symptomatic  improvement  on  therapeutic  levels. 
However his lung function continued to deteriorate and 
3 months later he died at the age of 46. 
Discussion:  Aspergillus spp.  are  widespread  and 
exposure to airborne conidia and hyphal fragments is 
universal.  In  humans  who  are  immunocompromised 
these  saprophytic  fungi  can  cause  life-threatening 
invasive aspergillosis and, in asthmatics and those with 
cystic  fibrosis,  allergic  disease  (allergic 
bronchopulmonary  aspergillosis  (ABPA)).  In  those 
who  have  structural  damage  to  their  lungs  but  are 
apparently  immunocompetent,  Aspergillus can  cause 
CPA, with or without an aspergilloma. 
Invasive  aspergillosis  has  been  described  in 
association  with  marijuana  smoking  in  two  cancer 
patients on chemotherapy,
1,2 two leukaemia patients,
3,4
a renal transplant recipient,
5 and a few patients with 
AIDS.
6 It is not recommended that patients undergoing 
chemotherapy  or  on  substantial  immunosuppression 
smoke  marijuana,  based  on  these  observations. 
However the risk is not possible to quantify. 
There  have  been  two  reported  cases  of  ABPA 
associated  with  mouldy  marijuana.
7,8 Given  the 
frequency  of  asthma  and  ABPA,  and  the  high 
frequency of marijuana usage amongst young people, 
these cases may represent a tiny proportion of those 
affected.  This  year,  CPA  was  associated  with 
marijuana  smoking  for  the  first  time
9 and  we  report 
here  2  additional  cases.    The  previously  reported 
patient died at just 34 years of age and patient 2 at 46 
years of age.  These high mortality rates of CPA have 
been described previously.
10-12
The  criteria  for  the  diagnosis  of  CPA  are  the 
presence  of  pulmonary  cavitation,  with  or  without  a 
fungal ball, in a non-immunocompromised patient with 
evidence  of  raised  inflammatory  markers  and 
detectable  circulating  Aspergillus IgG  antibodies 
(including Aspergillus precipitins).
13 The sensitivity of 
the  IgG  antibody  tests  is  about  90%,  with  some 
discordance between assays. Occasional patients do not 
have detectable IgG antibody, but their Aspergillus IgE 
antibodies  are  raised  and/or  there  are  other  data 
supporting  the  diagnosis,  such  as  biopsy  or  culture 
evidence  of  infection.  Patient  1  had  histological 
evidence  of  infection  with  detectable  Aspergillus
precipitins. Patient 2 had a positive respiratory culture, 
with a fungal ball visible radiologically, and detectable 
Aspergillus IgG and IgE antibodies, as well as positive 
Aspergillus precipitins.
Both  tobacco  and  marijuana  are  commonly 
contaminated with fungi, and serology from marijuana 
smokers exhibits evidence of Aspergillus exposure.
14 It 
remains to be seen whether fungal spores survive the 
burning  process,  indicating  perhaps  that  exposure  to 
Aspergillus comes from handling the marijuana rather 
than smoking it.
15 It has been observed that IA presents 
earlier  after  immunocompromise  amongst  smokers 
than non-smokers.
16
The way marijuana is smoked is different to that of 
tobacco  in  that  the  cigarettes,  or  joints,  are  usually 
smoked  without  a  filter  and  are  smoked  down  to  a 
smaller butt. Users hold their breath for longer and use 
the  Valsalva  manoeuvre.    These measures  maximise 
the diffusion of the psychoactive compounds. In doing 
so however, they expose their lungs to a greater tar and 
carbon  monoxide burden, as  well  as subjecting  their 
lungs  to  greater  pressure  changes.  This  barotrauma 
from marijuana smoking has long been associated with 
the  formation  of  bullae  and  subsequent 
pneumothoraces. The association is so strong that some 
now  recommend  that  patients  presenting  with 
spontaneous  pneumothoraces  should  be  directly 
questioned about marijuana smoking.
17
The vast  majority  of  marijuana  is  taken 
recreationally  for  its  psychotropic  effects.  However, 
historically  it  has  been  used  medicinally  as  an 
analgesic and an antiemetic. Even now, many people 
use marijuana purely for its medicinal benefits. It has 
been  reported  that  44%  of  US  oncologists  have 
recommended  the  illegal  use  of  marijuana  to  their 
chemotherapy patients for iatrogenic nausea.
18  What 
must  be  borne  in  mind  is  that  these  patients  are 
potentially  severely  immunosuppressed  and  therefore 
at risk of life-threatening IA. 
Smoking  marijuana  affects  the  lungs  structurally 
but may also affect them immunologically, by affecting 
alveolar  macrophages.
19 This  may  predispose 
marijuana users to pulmonary infection. In our cases it 
is unknown whether the marijuana smoking caused the 
cavities which Aspergillus was able to colonise, or the 
marijuana was just the source of Aspergillus exposure 
and the Aspergillus caused the cavities. Research into 
the pathogenesis of both marijuana-related lung bullae Mediterr J Hematol Infect Dis 2011, 3; Open Journal System
and CPA are needed to proportionate causal blame in 
cases such as these. 
Marijuana use has previously been implicated with 
the  range  of  Aspergillus infections;  the  cases  we 
present add aspergilloma and CPA to that list. In both 
cases  marijuana  was  used  for  its  medicinal  benefits. 
With patient 1 smoking marijuana in combination with 
mild  immunosuppression  through  low-dose  steroids 
proved  to  be  a  potent  combination.  In  patient  2  the 
heavy  and  prolonged  marijuana  usage  in  itself  may 
have resulted in extensive pulmonary destruction and 
fatal CPA. 
Together these cases highlight yet another potential 
risk associated with smoking marijuana. Understanding 
the  full  health  burden  presented  by  marijuana  is 
hindered by a lack of disclosure by patients for fear of 
legal repercussions, coupled with poor history taking 
from  clinicians;  just  3%  of  daily  marijuana  smokers 
have  their  drug  use  documented  in  their  clinical 
record.
20 More  work is  required to  elucidate the  full 
health burden of marijuana on those with pre-existing 
pathologies,  so  that  governments,  clinicians,  and 
indeed users can make informed decisions about this 
controversial topic. 
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